The 21st is the Century of Biology. A radical advancement in the knowledge of basic biology and human disease is transforming our world. We interview the heroes beneath the headlines.
| Platform |  | Pricing | Freemium | Publishes | Twice weekly |
|---|---|---|---|---|---|
| Issues | 597 | Founded | 3 years ago | Last Issue | 4 days ago |
| Active | |||||
Read this Newsletter
mendelspod.comLatest Issues
The Quest to Measure Protein Function with Polly Fordyce, Stanford
Stanford physicist and bioengineer Polly Fordyce has a big vision. She’s attempting to measure protein function at the scale at which we learned to measure DNA. We can sequence proteins. We can increasingly predict their structures. But we...
Doubling Down on Long Reads: New CEO of PacBio, Mark Van Oene
Mark Van Oene has just taken over as CEO of Pacific Biosciences, and Mendelspod is his first interview in the new job. He began his career as a scientist studying cystic fibrosis genetics at Toronto’s SickKids, then spent fifteen years at I...
Serge Saxonov on What’s Next for 10x Genomics
10x Genomics has been remarkably good at figuring out where biology is going next.
10x Genomics has been remarkably good at figuring out where biology is going next.
“You Cannot Discover What You Cannot Make”: Lee Cronin on Programming Chemistry
Those of us in biology tend to think that chemistry is rather straight forward.
Those of us in biology tend to think that chemistry is rather straight forward. But today’s guest says there’s quite an art to synthesizing a molecule.
All of Us Comes of Age. And So Does Its Funding: Josh Denny on the Next Phase of Precision Medicine
There are very few genomics projects with the level of ambition of the NIH All of Us Research Program. The latest release includes data from more than 747,000 participants, 535,000 whole genomes, 480,000 electronic health records, and—for t...
Audience Metrics
Subscribers, engagement, traffic and sponsorship for Mendelspod.
| Subscribers | Engagement | 70 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Chart Rankings
How this newsletter ranks in the official Substack charts.
| #141 | |
| #95 |
Authors
The writers behind this newsletter.
Podcaster and blogger. Host of Mendelspod & Five O'Clock with Theral Timpson
Producer
Frequently Asked Questions
How can I access the email archive for Mendelspod?
You can find recent issues that have been published by Mendelspod on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does Mendelspod have?
To see how many people subscribe to Mendelspod, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in Mendelspod?
Newsletter advertising can be extremely effective when it's done right. Before you pitch Mendelspod as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like Mendelspod?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Mendelspod using the contact information provided and ask for a copy of their media kit.
How can I find newsletters related to Mendelspod?
Scroll up to where it says Related Newsletters to see other publications like Mendelspod. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact Mendelspod?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.